Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial

Kathleen F. Harrington, Ralph DiClemente, Gina M. Wingood, Richard A. Crosby, Sharina Person, M. Kim Oh, Edward W. Hook

Research output: Contribution to journalArticle

Abstract

Background: Studies assessing the validity attributed to self-reported measures of sexually transmitted diseases (STDs) clearly are needed, particularly those used for high-risk populations such as female adolescents, in whom STD prevention is a priority. Goal: To determine the accuracy of self-reported STD test results in female adolescents over a relatively brief period (≈28 days). Study Design: A prospective, randomized, controlled clinical trial of STD/HIV prevention for African American females, ages 14 to 18, was conducted. Study participants were recruited from medical clinics and school health classes in low-income neighborhoods of Birmingham, Alabama, that had high rates of unemployment, substance abuse, violence, STDs, and teenage pregnancy. Results: Of the 522 adolescents enrolled in the trial, 92% (n = 479) completed baseline STD testing and follow-up surveys. At baseline, 28% had positive test results for at least one disease: 4.8 % for Neisseria gonorrhoeae, 17.1% for Chlamydia trachomatis, and 12.3% for Trichomonas vaginalis. Of the adolescents with negative STD test results, 98.8% were accurate in their self. report of STD status, as compared with 68.7% of the adolescents with positive results. Underreporting varied by type of STD. Adolescents who accurately reported their positive STD status were significantly more likely to report their receipt of treatment accurately (P < 0.001). Conclusions: The substantial underreporting of STD incidence in this study suggests that reliance on self-reports of STD history may introduce misclassification bias, potentially leading to false conclusions regarding the efficacy of prevention interventions. This observation highlights the importance of using biologic indicators as outcome measures.

Original languageEnglish (US)
Pages (from-to)468-471
Number of pages4
JournalSexually Transmitted Diseases
Volume28
Issue number8
DOIs
StatePublished - Jan 1 2001

Fingerprint

Sexually Transmitted Diseases
African Americans
HIV
Pregnancy in Adolescence
Trichomonas vaginalis
School Health Services
Unemployment
Ego
Neisseria gonorrhoeae
Chlamydia trachomatis
Medical Schools
Violence
Self Report
Substance-Related Disorders
Cohort Studies
Randomized Controlled Trials
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial. / Harrington, Kathleen F.; DiClemente, Ralph; Wingood, Gina M.; Crosby, Richard A.; Person, Sharina; Oh, M. Kim; Hook, Edward W.

In: Sexually Transmitted Diseases, Vol. 28, No. 8, 01.01.2001, p. 468-471.

Research output: Contribution to journalArticle

Harrington, Kathleen F. ; DiClemente, Ralph ; Wingood, Gina M. ; Crosby, Richard A. ; Person, Sharina ; Oh, M. Kim ; Hook, Edward W. / Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial. In: Sexually Transmitted Diseases. 2001 ; Vol. 28, No. 8. pp. 468-471.
@article{b1855ddad0a34a9f8dc0006fbcca341b,
title = "Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial",
abstract = "Background: Studies assessing the validity attributed to self-reported measures of sexually transmitted diseases (STDs) clearly are needed, particularly those used for high-risk populations such as female adolescents, in whom STD prevention is a priority. Goal: To determine the accuracy of self-reported STD test results in female adolescents over a relatively brief period (≈28 days). Study Design: A prospective, randomized, controlled clinical trial of STD/HIV prevention for African American females, ages 14 to 18, was conducted. Study participants were recruited from medical clinics and school health classes in low-income neighborhoods of Birmingham, Alabama, that had high rates of unemployment, substance abuse, violence, STDs, and teenage pregnancy. Results: Of the 522 adolescents enrolled in the trial, 92{\%} (n = 479) completed baseline STD testing and follow-up surveys. At baseline, 28{\%} had positive test results for at least one disease: 4.8 {\%} for Neisseria gonorrhoeae, 17.1{\%} for Chlamydia trachomatis, and 12.3{\%} for Trichomonas vaginalis. Of the adolescents with negative STD test results, 98.8{\%} were accurate in their self. report of STD status, as compared with 68.7{\%} of the adolescents with positive results. Underreporting varied by type of STD. Adolescents who accurately reported their positive STD status were significantly more likely to report their receipt of treatment accurately (P < 0.001). Conclusions: The substantial underreporting of STD incidence in this study suggests that reliance on self-reports of STD history may introduce misclassification bias, potentially leading to false conclusions regarding the efficacy of prevention interventions. This observation highlights the importance of using biologic indicators as outcome measures.",
author = "Harrington, {Kathleen F.} and Ralph DiClemente and Wingood, {Gina M.} and Crosby, {Richard A.} and Sharina Person and Oh, {M. Kim} and Hook, {Edward W.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1097/00007435-200108000-00009",
language = "English (US)",
volume = "28",
pages = "468--471",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial

AU - Harrington, Kathleen F.

AU - DiClemente, Ralph

AU - Wingood, Gina M.

AU - Crosby, Richard A.

AU - Person, Sharina

AU - Oh, M. Kim

AU - Hook, Edward W.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background: Studies assessing the validity attributed to self-reported measures of sexually transmitted diseases (STDs) clearly are needed, particularly those used for high-risk populations such as female adolescents, in whom STD prevention is a priority. Goal: To determine the accuracy of self-reported STD test results in female adolescents over a relatively brief period (≈28 days). Study Design: A prospective, randomized, controlled clinical trial of STD/HIV prevention for African American females, ages 14 to 18, was conducted. Study participants were recruited from medical clinics and school health classes in low-income neighborhoods of Birmingham, Alabama, that had high rates of unemployment, substance abuse, violence, STDs, and teenage pregnancy. Results: Of the 522 adolescents enrolled in the trial, 92% (n = 479) completed baseline STD testing and follow-up surveys. At baseline, 28% had positive test results for at least one disease: 4.8 % for Neisseria gonorrhoeae, 17.1% for Chlamydia trachomatis, and 12.3% for Trichomonas vaginalis. Of the adolescents with negative STD test results, 98.8% were accurate in their self. report of STD status, as compared with 68.7% of the adolescents with positive results. Underreporting varied by type of STD. Adolescents who accurately reported their positive STD status were significantly more likely to report their receipt of treatment accurately (P < 0.001). Conclusions: The substantial underreporting of STD incidence in this study suggests that reliance on self-reports of STD history may introduce misclassification bias, potentially leading to false conclusions regarding the efficacy of prevention interventions. This observation highlights the importance of using biologic indicators as outcome measures.

AB - Background: Studies assessing the validity attributed to self-reported measures of sexually transmitted diseases (STDs) clearly are needed, particularly those used for high-risk populations such as female adolescents, in whom STD prevention is a priority. Goal: To determine the accuracy of self-reported STD test results in female adolescents over a relatively brief period (≈28 days). Study Design: A prospective, randomized, controlled clinical trial of STD/HIV prevention for African American females, ages 14 to 18, was conducted. Study participants were recruited from medical clinics and school health classes in low-income neighborhoods of Birmingham, Alabama, that had high rates of unemployment, substance abuse, violence, STDs, and teenage pregnancy. Results: Of the 522 adolescents enrolled in the trial, 92% (n = 479) completed baseline STD testing and follow-up surveys. At baseline, 28% had positive test results for at least one disease: 4.8 % for Neisseria gonorrhoeae, 17.1% for Chlamydia trachomatis, and 12.3% for Trichomonas vaginalis. Of the adolescents with negative STD test results, 98.8% were accurate in their self. report of STD status, as compared with 68.7% of the adolescents with positive results. Underreporting varied by type of STD. Adolescents who accurately reported their positive STD status were significantly more likely to report their receipt of treatment accurately (P < 0.001). Conclusions: The substantial underreporting of STD incidence in this study suggests that reliance on self-reports of STD history may introduce misclassification bias, potentially leading to false conclusions regarding the efficacy of prevention interventions. This observation highlights the importance of using biologic indicators as outcome measures.

UR - http://www.scopus.com/inward/record.url?scp=0034910609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034910609&partnerID=8YFLogxK

U2 - 10.1097/00007435-200108000-00009

DO - 10.1097/00007435-200108000-00009

M3 - Article

C2 - 11473220

AN - SCOPUS:0034910609

VL - 28

SP - 468

EP - 471

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 8

ER -